Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis are generally
thought to have high mortality rates. However, many cases can be treated with the right …

Multidrug-resistant (MDR) tuberculosis is a growing clinical and public-health concern. To
evaluate existing evidence regarding treatment regimens for MDR tuberculosis, we used a …

Background Treatment of multi-drug resistant tuberculosis (MDR-TB) for a prolonged period
with comparatively less effective and more toxic second-line anti-TB drugs is associated with …

Background Treatment of multidrug-resistant tuberculosis requires long-term therapy with a
combination of multiple second-line drugs. These drugs are associated with numerous …

SETTING: Niger National Tuberculosis Programme. Regions supported by the Damien
Foundation. OBJECTIVE: To evaluate the effectiveness of a short-course standardised …

Background Treatment of drug susceptible tuberculosis (DS-TB) requires regimens
containing first line drugs (FLDs') whereas drug resistant tuberculosis (DR-TB) are treated …

Os objetivos principais do tratamento da tuberculose são curar o paciente e minimizar a
possibilidade de transmissão do bacilo para indivíduos saudáveis. Reações adversas ou …

The emergence of drug-resistant strains of Mycobacterium tuberculosis is a challenge to
global tuberculosis (TB) control. Although culture-based methods have been regarded as …

The Objective of this analysis was to identify predictors of death, failure, and default among
MDR-TB patients treated with second-line drugs in DOTS-plus projects in Estonia, Latvia …

Tuberculosis (TB) remains a major public health problem, representing the second leading
cause of death from infectious diseases globally, despite being nearly 100% curable …